High
and ever-prevailing incidence of trauma wounds, injuries, burns and
chronic wounds such as diabetic foot ulcers creates a constant and
steady demand for wound dressing. Furthermore, wound dressing is an
integral part of post-surgery in order to minimize risk of hospital
acquired infections (HAIs). Therefore, with increasing surgical
procedures, demand for wound dressings is expected to increase
consequently during the forecast period (2016-2024). With
technological advancements, wound dressings made of various materials
such as alginates, collagens, hydrocolloids, hydrofibers, and
hydrogels have been commercialized in the wound dressings market.
Depending on the condition or wound type, an appropriate wound
dressing is selected. Market players such as 3M Company, Coloplast
Corp., and Derma Sciences, Inc. are constantly focusing on extensive
R&D activities in order to offer cost-effective wound dressing
products to further enhance their market presence.
Download
Free PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/142
Market
Dynamics
Most
conventional wound dressings take longer to heal wounds as compared
to advanced wound dressing products such as anti-infective wound
dressings that are widely used post-operation to prevent risk of any
hospital acquired infections (HAIs). Due to their higher functional
efficiency and effectiveness, advanced wound dressings are fast
replacing conventional wound dressings. Increasing incidence of
burns, trauma wounds and injuries, and diabetic ulcers are expected
to drive growth of the global wound dressings market in the
foreseeable future. Rural areas in emerging economies of Asia, Latin
America and Africa regions provide a highly lucrative and largely
untapped market for market players to capitalize upon. Practice of
using cotton gauze and sterile cotton is still high in emerging
economies such as India, Brazil, China, and Indonesia, owing to it
being easily available and being relatively inexpensive.
The
global wound dressings market was valued at US$ 8,269.5 million in
2015 and is expected to witness a moderate CAGR of 6.0% during the
forecast period (2016 – 2024).
Increasing
patient pool is expected to drive growth of the global wound
dressings market
According
to the American Diabetes Association (ADA), around 1% to 4% of the
diabetic population in the U.S are estimated to be affected by
diabetic foot ulcers annually. Moreover, according to Diabetes UK,
prevalence of diabetic foot ulcers in diabetic patients is estimated
to be 2.5%, which accounts for around 86,000 people in the U.K. in
2015. Moreover, according to the organization, around 7,400 leg, foot
or toe amputation procedures are conducted every year in England. As
per the estimation by The American Journal of Internal Medicine,
around half of the diabetic population in Canada have at least one
hospitalization in their lifespan for the treatment of diabetic foot
infection.
Market
Players
Key
companies covered as a part of this study include 3M Company,
Coloplast A/S, Derma Sciences, Inc., Smith & Nephew plc,
Medtronic, Mölnlycke Healthcare, Medline Industries, Inc.,
Organogenesis Inc., Alliqua BioMedical, Inc., Integra LifeSciences
Corporation, and MiMedx Group, Inc.
Detailed
Segmentation:
Global
Wound Dressing Market, By Product Type:
Traditional
Advanced
-
Alginates
-
Collagens
-
Films
-
Foams
-
Hydrocolloids
-
Hydrogels
-
Wound Contact Layers
For
More Information, Browse Full Report Here:
https://www.coherentmarketinsights.com/market-insight/wound-dressing-market-142
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment